Compare Ecopetrol SA (EC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs ResMed Inc. — how do they compare? Ecopetrol SA trades at $16.91 (market cap $33.11B), while ResMed Inc. trades at $230.12 (market cap $31.89B). The key difference: Ecopetrol SA and ResMed Inc. are close in size by market cap, and Ecopetrol SA pays the higher dividend (3.83%). Which is the better fit depends on your goals — on Pluang, investors hold Ecopetrol SA for 84 Days and ResMed Inc. for 51 Days on average.
| EC | RMD | |
|---|---|---|
Market Cap | $33.11B | $31.89B |
Volume | 993,598 | 618,314 |
Sector | Energy | Health |
52-Week High | $18.26 | $277.88 |
52-Week Low | $8.61 | $182.82 |
Typical Hold Time | 84 Days | 51 Days |
Enterprise Value | $61.36B | $31.24B |
Dividend Yield | 3.83% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $17.07, up 2.65% on the day, but faces a bearish technical signal with recent earnings misses. Revenue declined to $119.69T in 2025, with net income margin at 8.76%, though profitability metrics like ROE (17.67%) remain solid. The company is undergoing senior management changes amid government-led board restructuring, creating uncertainty.
The outlook is mixed: low valuations (P/E 7.97, EV/EBITDA 4) suggest potential upside, but declining revenue, earnings volatility, and political interference pose significant risks. Analyst consensus is cautious with a $16.85 price target below current levels, indicating limited near-term catalysts for substantial growth.
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
